Condition
Multiple Primary Lung Cancers
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 2 (2)
Trial Status
Unknown3
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT06699979Recruiting
Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes
NCT04982900Phase 2UnknownPrimary
Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities
NCT04326751UnknownPrimary
Evolution of Multiple Primary Lung Cancer (Evolution)
NCT04026841Phase 2UnknownPrimary
The Efficacy of PD-1 Antibody Sintilimab on Early-stage Multiple Primary Lung Cancer With Ground Glass Density.
Showing all 4 trials